IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen.
about
The role of microbiome in central nervous system disordersRole of overexpressed CFA/I fimbriae in bacterial swimming.IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE)Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression.Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritisBystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β.IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitisNeuroimmunology of the Interleukins 13 and 4.Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate.A tale of two STAT6 knock out mice in the induction of experimental autoimmune encephalomyelitis.IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function.Regulatory T-cell vaccination independent of auto-antigen.Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs.IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis.Attenuated Salmonella sp. as a DNA Delivery System for Trypanosoma cruzi Antigens.The gut microbiome in multiple sclerosis.Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord InjuryGut-CNS-Axis as Possibility to Modulate Inflammatory Disease Activity-Implications for Multiple SclerosisAmelioration of EAE by a cryptic epitope of myelin oligodendrocyte glycoprotein.Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets.Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells.Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study.IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Regulatory T Cell Suppression To Restrain Experimental Allergic Encephalomyelitis.On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes.Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.Targeted intracerebral delivery of the anti-inflammatory cytokine IL13 promotes alternative activation of both microglia and macrophages after stroke.
P2860
Q28304749-C3C0373F-3A5D-44B6-9AA8-E8737C62809CQ30519498-CFD49680-0A8C-4C20-834C-1575F8864273Q33525565-1B0CBCE8-41B2-4539-AC22-5DDCEDB20C29Q35134310-0CA292F9-49CB-4AA5-9F7D-89224464CD3BQ35558638-EC1B5995-DB3F-4E6D-A1C4-3EACA1C3BAB9Q35609379-30FDD9ED-7BA6-422A-8195-E329DFF2F368Q35610749-04ED959A-FB31-4FF6-928D-B02AA4C8DD64Q35894777-0CFF7D87-4A6D-41A2-8745-C9398558DE3FQ36091277-3D5754A2-2E7D-4494-A5D6-1F11E06A5E35Q36831790-EE6543EC-4296-44F5-BA28-FDE262EEBA99Q37061593-B06E147D-40BA-4260-B242-0638DCDC0928Q37120358-2A9C26CA-39E8-4387-98A6-C2408E43DDBAQ37388179-0F33BE19-36A6-437D-94D1-98C766643A49Q37647886-93A21415-2B78-4BCD-A9A1-A2E71630A81CQ37679455-C0267EA2-E52D-4AEC-A4EB-4483B0CCB18FQ37700861-C335682C-6472-4172-A5D8-67483D09D3FAQ38617794-7313C682-547F-4675-A9E5-263E02E30E9BQ38778385-CCF050B0-7647-4524-A5F4-ABF7B68DD656Q39021579-C0E45D6A-526E-45BF-92B9-24BE2CDF2CB7Q39100756-2434D6DC-35FE-4A01-AF8A-25BD9C51F0D3Q39434933-ABD1DB44-1188-456A-BA81-CAFFB8B8C64DQ39594953-047881F8-928F-4C71-91E9-2AEF99BCBA42Q41518676-47249612-5836-4CBF-B238-BC4A953C0440Q46325643-822D746E-DA7A-4C84-8B7E-954C83A9A5D1Q47102802-F66FAE31-856D-40C4-9CBF-5E15DD134831Q47962577-7FD3A4B3-CBFE-474D-9F7C-1C983C1657C8Q48228458-EFC571CC-85FE-4146-998C-5C7EE7F871D1Q49161820-27DE700A-C41F-440C-A71D-5FFCF8C4913DQ55236740-760C3E4F-1FC0-4535-8B67-C6A49ECA833BQ55488324-5E82E6D4-1BD6-4A10-9A49-465DE64F3720
P2860
IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-13 production by regulatory ...... independently of autoantigen.
@en
IL-13 production by regulatory ...... independently of autoantigen.
@nl
type
label
IL-13 production by regulatory ...... independently of autoantigen.
@en
IL-13 production by regulatory ...... independently of autoantigen.
@nl
prefLabel
IL-13 production by regulatory ...... independently of autoantigen.
@en
IL-13 production by regulatory ...... independently of autoantigen.
@nl
P2093
P2860
P1476
IL-13 production by regulatory ...... independently of autoantigen.
@en
P2093
Agnieszka Rynda
Carol Riccardi
David W Pascual
Gayle Callis
Irina Kochetkova
Javier Ochoa-Repáraz
Miguel A Ascón
Theresa Trunkle
Xinghong Yang
P2860
P304
P356
10.4049/JIMMUNOL.181.2.954
P407
P577
2008-07-01T00:00:00Z